Gsa Capital Partners LLP Humacyte, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2024
A detailed history of Gsa Capital Partners LLP transactions in Humacyte, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 224,179 shares of HUMA stock, worth $1.25 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
224,179
Previous 199,049
12.63%
Holding current value
$1.25 Million
Previous $619,000
73.83%
% of portfolio
0.08%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding HUMA
# of Institutions
130Shares Held
30.8MCall Options Held
323KPut Options Held
582K-
Black Rock Inc. New York, NY7.14MShares$39.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$26.4 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$16 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$10.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.6MShares$8.92 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $575M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...